Catalog No.
PVV20301
Species reactivity
Human enterovirus 71 (EV71) (EV-71)
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant EV71 VP1/Capsid protein VP1 (Gly566-Leu862).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:200, WB: 1:500-1:4000
Target
Genome polyprotein, P1, Capsid protein VP1, P1D, Virion protein 1
Concentration
0.5 mg/ml
Purification
Purified by antigen affinity column.
Accession
A0A894JU04
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease., PMID:38705805
Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice., PMID:37058406
Intranasal immunization with curdlan induce Th17 responses and enhance protection against enterovirus 71., PMID:36863926
[Preparation of monoclonal antibody against enterovirus 71 capsid protein VP1]., PMID:35365993
Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion., PMID:34997684
[Preparation of pan-neutralizing mouse monoclonal antibodies against enterovirus 71 and coxsackievirus A16]., PMID:34140076
Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection., PMID:34116877
Transplantation of Enterovirus 71 Virion Protein Particle Vaccine Protects Against Enterovirus 71 Infection in a Neonatal Mouse Model., PMID:33397838
Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein., PMID:33297428
Human Antibodies to VP4 Inhibit Replication of Enteroviruses Across Subgenotypes and Serotypes, and Enhance Host Innate Immunity., PMID:33101238
Epitope Peptide Amphiphile-Based Nanofiber as an Effective Vaccine for Viral Infectious Diseases., PMID:32331099
Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection., PMID:31805650
VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment., PMID:31787970
Target-Induced Cascade Amplification for Homogeneous Virus Detection., PMID:31698906
Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris., PMID:31403352
Neutrophil extracellular traps induced by VP1 contribute to pulmonary edema during EV71 infection., PMID:31285854
Enterovirus type 71-immunized chicken egg yolk immunoglobulin has cross antiviral activity against coxsackievirus A16 in vitro., PMID:31258670
Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice., PMID:31119429
A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge., PMID:30735461
The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus., PMID:30650163
Induction of immune responses by a novel recombinant fusion protein of enterovirus A71 in BALB/c mice., PMID:30465931
Analysis of an Imported Subgenotype C2 Strain of Human Enterovirus 71 in Beijing, China, 2015., PMID:30323801
[Preparation of mouse monoclonal antibodies against EV71 capsid protein VP1]., PMID:30043737
VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection., PMID:29848582
Non-neutralizing Antibody Responses against VP1 in Enterovirus A, B, C and Rhinovirus A species among Infants and Children in Shanghai., PMID:29615683
Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71., PMID:29582164
Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2)., PMID:29356992
Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo., PMID:29337652
Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice., PMID:29129453
Alanine scanning mutagenesis of SP70 epitope in characterizing species‑specific antibodies induced by enterovirus 71‑based antigens., PMID:29115505
Specific Unbinding Forces Between Mutated Human P-Selectin Glycoprotein Ligand-1 and Viral Protein-1 Measured Using Force Spectroscopy., PMID:29016136
A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus., PMID:28408118
Recombinant heat shock protein 78 enhances enterovirus 71 propagation in Vero cells and is induced in SK-N-SH cells during the infection., PMID:28236071
A Molecular Approach Applied to Enteroviruses Surveillance in Northern Taiwan, 2008-2012., PMID:27907198
A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice., PMID:27771182
Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1., PMID:27618897
[Preparation of monoclonal antibodies against enterovirus type 71 with an epitope-incorporated adenovirus type 3 vector]., PMID:27412945
Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges., PMID:27373596
Enhancing immune responses of EV71 VP1 DNA vaccine by co-inoculating plasmid IL-12 or GM-CSF expressing vector in mice., PMID:27188732
Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine., PMID:27068365
Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody., PMID:26938634
Serological detection and analysis of anti-VP1 responses against various enteroviruses (EV) (EV-A, EV-B and EV-C) in Chinese individuals., PMID:26917423
Enterovirus 71 transmission by exosomes establishes a productive infection in human neuroblastoma cells., PMID:26837894
Protein microarray-mediated detection of antienterovirus antibodies in serum., PMID:26831405
EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge., PMID:26809443
Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection., PMID:26529069
Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry., PMID:26401034
Development of a Specific Latex Agglutination Test to Detect Antibodies of Enterovirus 71., PMID:26363276
Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71., PMID:26296491
A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71., PMID:26243660
For research use only. Not for human or drug use.
